Literature DB >> 21123169

Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.

Zvjezdana Sever-Chroneos1, Agnieszka Krupa, Jeremy Davis, Misbah Hasan, Ching-Hui Yang, Jacek Szeliga, Mathias Herrmann, Muzafar Hussain, Brian V Geisbrecht, Lester Kobzik, Zissis C Chroneos.   

Abstract

Staphylococcus aureus causes life-threatening pneumonia in hospitals and deadly superinfection during viral influenza. The current study investigated the role of surfactant protein A (SP-A) in opsonization and clearance of S. aureus. Previous studies showed that SP-A mediates phagocytosis via the SP-A receptor 210 (SP-R210). Here, we show that SP-R210 mediates binding and control of SP-A-opsonized S. aureus by macrophages. We determined that SP-A binds S. aureus through the extracellular adhesin Eap. Consequently, SP-A enhanced macrophage uptake of Eap-expressing (Eap(+)) but not Eap-deficient (Eap(-)) S. aureus. In a reciprocal fashion, SP-A failed to enhance uptake of Eap(+) S. aureus in peritoneal Raw264.7 macrophages with a dominant negative mutation (SP-R210(DN)) blocking surface expression of SP-R210. Accordingly, WT mice cleared infection with Eap(+) but succumbed to sublethal infection with Eap- S. aureus. However, SP-R210(DN) cells compensated by increasing non-opsonic phagocytosis of Eap(+) S. aureus via the scavenger receptor scavenger receptor class A (SR-A), while non-opsonic uptake of Eap(-) S. aureus was impaired. Macrophages express two isoforms: SP-R210(L) and SP-R210(S). The results show that WT alveolar macrophages are distinguished by expression of SP-R210(L), whereas SR-A(-/-) alveolar macrophages are deficient in SP-R210(L) expressing only SP-R210(S). Accordingly, SR-A(-/-) mice were highly susceptible to both Eap(+) and Eap(-) S. aureus. The lungs of susceptible mice generated abnormal inflammatory responses that were associated with impaired killing and persistence of S. aureus infection in the lung. In conclusion, alveolar macrophage SP-R210(L) mediates recognition and killing of SP-A-opsonized S. aureus in vivo, coordinating inflammatory responses and resolution of S. aureus pneumonia through interaction with SR-A.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123169      PMCID: PMC3039347          DOI: 10.1074/jbc.M110.125567

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  105 in total

1.  Survival of Staphylococcus aureus inside neutrophils contributes to infection.

Authors:  H D Gresham; J H Lowrance; T E Caver; B S Wilson; A L Cheung; F P Lindberg
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

2.  Tumor necrosis factor primes neutrophils to kill Staphylococcus aureus by an oxygen-dependent mechanism and Plasmodium falciparum by an oxygen-independent mechanism.

Authors:  I C Kowanko; A Ferrante; G Clemente; L M Kumaratilake
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  The effect of class a scavenger receptor deficiency in bone.

Authors:  Yi-Ling Lin; Willem J S de Villiers; Beth Garvy; Steven R Post; Tim R Nagy; Fayez F Safadi; Marie Claude Faugere; Guodong Wang; Hartmut H Malluche; John P Williams
Journal:  J Biol Chem       Date:  2006-12-13       Impact factor: 5.157

Review 4.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

5.  Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages.

Authors:  Szczepan Józefowski; Lester Kobzik
Journal:  J Leukoc Biol       Date:  2004-08-17       Impact factor: 4.962

6.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

7.  Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A.

Authors:  Koji Kuronuma; Hitomi Sano; Kazunori Kato; Kazumi Kudo; Naoki Hyakushima; Shin-ichi Yokota; Hiroki Takahashi; Nobuhiro Fujii; Hiroshi Suzuki; Tatsuhiko Kodama; Shosaku Abe; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

8.  Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues.

Authors:  Alice G Cheng; Hwan Keun Kim; Monica L Burts; Thomas Krausz; Olaf Schneewind; Dominique M Missiakas
Journal:  FASEB J       Date:  2009-06-12       Impact factor: 5.191

9.  Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling.

Authors:  Alexandra I Medeiros; Carlos H Serezani; Sang Pyo Lee; Marc Peters-Golden
Journal:  J Exp Med       Date:  2009-01-05       Impact factor: 14.307

10.  Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus.

Authors:  Changping Xie; Pilar Alcaide; Brian V Geisbrecht; Darius Schneider; Mathias Herrmann; Klaus T Preissner; Francis W Luscinskas; Triantafyllos Chavakis
Journal:  J Exp Med       Date:  2006-04-03       Impact factor: 14.307

View more
  36 in total

Review 1.  Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.

Authors:  Frederico Vieira; Johannes W Kung; Faizah Bhatti
Journal:  Ann Anat       Date:  2017-03-27       Impact factor: 2.698

2.  Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Carmen Fernández
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

Review 3.  Recent progress on surfactant protein A: cellular function in lung and kidney disease development.

Authors:  Skylar D King; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

Review 4.  Surfactant and its role in the pathobiology of pulmonary infection.

Authors:  Jennifer R Glasser; Rama K Mallampalli
Journal:  Microbes Infect       Date:  2011-09-10       Impact factor: 2.700

Review 5.  MYO18A: An unusual myosin.

Authors:  Matthew D Buschman; Seth J Field
Journal:  Adv Biol Regul       Date:  2017-09-18

Review 6.  The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Paola Aranda-Valderrama; Ata Murat Kaynar
Journal:  Int Anesthesiol Clin       Date:  2018

7.  GM-CSF modulates pulmonary resistance to influenza A infection.

Authors:  Zvjezdana Sever-Chroneos; Aditi Murthy; Jeremy Davis; Jon Matthew Florence; Anna Kurdowska; Agnieszka Krupa; Jay W Tichelaar; Mitchell R White; Kevan L Hartshorn; Lester Kobzik; Jeffrey A Whitsett; Zissis C Chroneos
Journal:  Antiviral Res       Date:  2011-09-08       Impact factor: 5.970

8.  Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.

Authors:  Andreas Schwingshackl; Benjamin Lopez; Bin Teng; Charlean Luellen; Florian Lesage; John Belperio; Riccardo Olcese; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

9.  Novel role of surfactant protein A in bacterial sinusitis.

Authors:  George T Noutsios; Amanda L Willis; Julie G Ledford; Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2017-07-20       Impact factor: 3.858

10.  Phagocytosis of live versus killed or fluorescently labeled bacteria by macrophages differ in both magnitude and receptor specificity.

Authors:  Angelika Peruń; Rafał Biedroń; Maciej K Konopiński; Anna Białecka; Janusz Marcinkiewicz; Szczepan Józefowski
Journal:  Immunol Cell Biol       Date:  2016-11-09       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.